Likewise, we observed PD-L1 expression on ex vivo-activated B-cells (data not shown), presumably indicating that the systemic administration of anti-PD-L1 antibodies prevents exhaustion of not only the tumor-infiltrating antigen-specific T-cells but also infused antigen-loaded B-cells to preserve prolonged APC function. Here, CD274 is linked to neoplasm.